Addressing Treatment Resistance in Childhood Acute Lymphoblastic Leukemia

Treatment of childhood leukemia has improved markedly in recent decades, with long-term cure achieved in most patients who have access to modern, highly intensive treatment regimens. However, some patients develop resistance to the steroid drugs which are a key part of combination chemotherapy treatments, which results in poor clinical outcomes.

In the third week of PLOS Medicine's ongoing special issue on cancer genomics, principal investigator Jules Meijerink of the Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands and colleagues seek to identify mechanisms underlying treatment resistance in children with T-cell acute lymphoblastic leukemia (T-ALL) by combining genomic DNA sequencing and chromosomal copy-number analyses, and suggest a new approach to therapy.

As described in their Research Article, Meijerink and colleagues studied genetic changes in leukemic cells from pediatric T-ALL patients before treatment. The researchers found specific gene mutations affecting signaling inside cells, involving the interleukin 7 receptor and downstream molecules, that were associated with steroid resistance and adverse clinical outcome. Drugs designed to target individual signaling proteins were able to restore steroid sensitivity to primary leukemic cells from patients.

‘Inhibition of MEK-ERK or PI3K/AKT/mTOR signaling could enhance steroid sensitivity in children with T-cell acute lymphoblastic leukemia (T-ALL) and potentially improve patient outcomes.’

Discussing the research in an accompanying Perspective article, Steven Goossens and Pieter Van Vlierberghe conclude that "inhibition of MEK-ERK or PI3K/AKT/mTOR signaling could enhance steroid sensitivity in T-ALL and potentially improve patient outcomes, a notion that warrants investigation in future prospective clinical trials."

Source: Eurekalert

Intermittent Fasting can Kill Cancer Cells of Childhood Leukemia

Acute lymphoblastic leukemia, the most common type of leukemia found in children, can occur at any age. Acute myeloid leukemia (AML) is more common in adults.

In Hispanic Patients Hereditary Risk Factors for Childhood Leukemia Are More Common

In comparison to other racial and ethnic backgrounds Hispanic kids are more likely to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease.

Abnormal Gene That Launches Rare Childhood Leukemia Identified By Gene Sequencing Project

Research has identified a fusion gene responsible for almost 30 percent of of a rare subtype of childhood leukemia with an extremely poor prognosis.

New Treatment Options for High-Risk Childhood Leukemia Subtype Via Existing Drugs

New genetic alterations underlying a high-risk subtype of the most common childhood cancer have been identified by scientists.

Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.

Acute Myeloid Leukemia

Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults alike

Bone Marrow Transplantation

Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are injected into a recipient after treating them with growth factor.

Chronic Myeloid Leukemia

Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone marrow.

Hairy Cell Leukemia

Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymphocytes, a type of white blood cells.

Leukemia

Encyclopedia section of medindia gives general information about Leukemia

Multiple Myeloma

Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Mehta’s ‘Water’ , declared that she had the incurable Multiple Myeloma.